We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+11.18%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$20.3B
AUM Growth
+$2.3B
Cap. Flow
+$1.2B
Cap. Flow %
5.92%
Top 10 Hldgs %
11.58%
Holding
2,274
New
1,012
Increased
361
Reduced
318
Closed
569

Top Buys

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$172M
2
TGT icon
Target
TGT
+$132M
3
BNY
Bank of New York Mellon
BNY
+$121M
4
ZTS icon
Zoetis
ZTS
+$109M
5
COHR
Coherent Inc
COHR
+$105M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$239M
2
BABA icon
Alibaba
BABA
+$153M
3
PYPL icon
PayPal
PYPL
+$141M
4
DIS icon
Walt Disney
DIS
+$128M
5
BAC icon
Bank of America
BAC
+$121M

Sector Composition

Rank Sector Weight
1 Financials 13.52%
2 Technology 12.05%
3 Consumer Discretionary 11.11%
4 Healthcare 10.5%
5 Industrials 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSAQW
1676
DELISTED
Global Synergy Acquisition Corp. Warrant
GSAQW
$56K ﹤0.01%
+108,069
New +$81.3K
BEST
1677
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$54K ﹤0.01%
1,435
-1,763
-55% -$80.2K
EFTRW
1678
DELISTED
eFFECTOR Therapeutics, Inc. Warrant
EFTRW
$54K ﹤0.01%
+88,566
New +$85.5K
INFI
1679
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$54K ﹤0.01%
+16,873
New +$56.3K
GNACW
1680
DELISTED
Group Nine Acquisition Corp. Warrant
GNACW
$50K ﹤0.01%
+75,075
New +$65.1K
HHLA.WS
1681
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$49K ﹤0.01%
+62,500
New +$46.8K
NMTR
1682
DELISTED
9 Meters Biopharma
NMTR
$49K ﹤0.01%
+2,093
New +$64.3K
DS
1683
DELISTED
Drive Shack Inc.
DS
$48K ﹤0.01%
+14,947
New +$40.6K
HCCCW
1684
DELISTED
Healthcare Capital Corp. Warrant
HCCCW
$47K ﹤0.01%
+75,000
New +$51.2K
TNXP icon
1685
Tonix Pharmaceuticals
TNXP
$193M
– –
0
– –
ABUS icon
1686
Arbutus Biopharma
ABUS
$923M
$40K ﹤0.01%
+12,147
New +$46.9K
SSAAW
1687
DELISTED
Science Strategic Acquisition Corp. Alpha Warrant
SSAAW
$40K ﹤0.01%
+66,666
New +$41.5K
HYMC icon
1688
Hycroft Mining Holding Corp
HYMC
$2.52B
$39K ﹤0.01%
+1,109
New +$75.4K
HCIIW
1689
DELISTED
Hudson Executive Investment Corp. II Warrant
HCIIW
$39K ﹤0.01%
+50,000
New +$47.5K
ZWRKW
1690
DELISTED
Z-Work Acquisition Corp. Warrant
ZWRKW
$36K ﹤0.01%
+50,000
New +$34.6K
CLIM.WS
1691
DELISTED
Climate Real Impact Solutions II Acquisition Corporation Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
CLIM.WS
$33K ﹤0.01%
+30,000
New +$47.2K
CASI
1692
DELISTED
CASI Pharmaceuticals
CASI
$32K ﹤0.01%
+1,317
New +$37K
ACII.WS
1693
DELISTED
Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
ACII.WS
$32K ﹤0.01%
+37,500
New +$37.8K
OTLK icon
1694
Outlook Therapeutics
OTLK
$208M
$31K ﹤0.01%
+688
New +$26.3K
MIT.WS
1695
DELISTED
Mason Industrial Technology, Inc. Redeemable warrants, exercisable for one share of Class A common stock for $11.50 per share
MIT.WS
$31K ﹤0.01%
+50,000
New +$32.6K
LMACW
1696
DELISTED
Liberty Media Acquisition Corporation Warrants
LMACW
$30K ﹤0.01%
+10,000
New +$39.1K
TTOO
1697
DELISTED
T2 Biosystems, Inc
TTOO
$29K ﹤0.01%
+4
New +$42.4K
HCICW
1698
DELISTED
Hennessy Capital Investment Corp. V Warrant
HCICW
$29K ﹤0.01%
+25,000
New +$36.3K
SVRA icon
1699
Savara
SVRA
$1.17B
$24K ﹤0.01%
+11,512
New +$19.7K
MARK
1700
DELISTED
Remark Holdings, Inc.
MARK
$24K ﹤0.01%
+1,059
New +$30.2K
66 67
68
69 70

Similar funds

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Balyasny Asset Management's Q1 2021 Portfolio in Review

As of Q1 2021, Balyasny Asset Management held 2,274 positions worth $20.3B, up 13% from $18B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Balyasny Asset Management deployed $1.2B of net new capital in Q1 2021, opening 1,012 new positions and adding to 361 existing holdings. Its largest new stake was Wells Fargo: 4,853,470 shares worth $190M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $239M trimmed.

  • Balyasny Asset Management's largest Q1 2021 buy was Wells Fargo: 4,853,470 shares worth $190M.
  • Balyasny Asset Management added most to Target in Q1 2021, an estimated $132M increase.
  • Balyasny Asset Management's biggest Q1 2021 reduction was Alphabet (Google) Class A, cutting an estimated $239M.
  • Balyasny Asset Management fully exited PayPal in Q1 2021, selling an estimated $141M.
  • Balyasny Asset Management's ten largest holdings make up 12% of its $20.3B portfolio in Q1 2021.
  • Balyasny Asset Management opened 1,012 new positions and closed 569 in Q1 2021.
  • Balyasny Asset Management's portfolio value rose 13% quarter-over-quarter to $20.3B.

Based on Balyasny Asset Management's 13F filing for Q1 2021, filed 17 May 2021.